Efficacy and Safety of Evogliptin in Mild to Moderate Calcific Aortic Valve Stenosis: The EVOID-AS Trial Rationale and Study Design
- DOI
- 10.1016/j.mayocp.2026.08.017
- Published
- 2026-11
- Container
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.mayocp.2026.08.017,
title = {Efficacy and Safety of Evogliptin in Mild to Moderate Calcific Aortic Valve Stenosis: The EVOID-AS Trial Rationale and Study Design},
author = {Ratnasari Padang and Roberto Hodara and M. Fuad Jan and Renuka Jain and Alexander Postalian and Bryan M. Zweig and Tasneem Z. Naqvi and Robert A. Levine and Jacob P. Dal-Bianco and Edgar Argulian and Gregg S. Pressman and Partho P. Sengupta and Amr E. Abbas and Wayne Cheng and Ankitkumar K. Patel and Nicole M. Bhave and Eugene S. Chung and Carlos E. Sanchez and Trace C. Barrett and Smadar Kort and Jina Sohn and Peter Pollak and Mays T. Ali and Scott Chadderdon and Qiong Zhao and Edward Gill and Fredy El Sakr and Naveen L. Pereira and Adrian Vella and Phillip J. Schulte and Kent R. Bailey and Jae-Kwan Song and Jae K. Oh},
year = {2026},
journal = {Mayo Clinic Proceedings},
doi = {10.1016/j.mayocp.2026.08.017},
url = {https://doi.org/10.1016/j.mayocp.2026.08.017}
}RIS
TY - JOUR TI - Efficacy and Safety of Evogliptin in Mild to Moderate Calcific Aortic Valve Stenosis: The EVOID-AS Trial Rationale and Study Design AU - Ratnasari Padang AU - Roberto Hodara AU - M. Fuad Jan AU - Renuka Jain AU - Alexander Postalian AU - Bryan M. Zweig AU - Tasneem Z. Naqvi AU - Robert A. Levine AU - Jacob P. Dal-Bianco AU - Edgar Argulian AU - Gregg S. Pressman AU - Partho P. Sengupta AU - Amr E. Abbas AU - Wayne Cheng AU - Ankitkumar K. Patel AU - Nicole M. Bhave AU - Eugene S. Chung AU - Carlos E. Sanchez AU - Trace C. Barrett AU - Smadar Kort AU - Jina Sohn AU - Peter Pollak AU - Mays T. Ali AU - Scott Chadderdon AU - Qiong Zhao AU - Edward Gill AU - Fredy El Sakr AU - Naveen L. Pereira AU - Adrian Vella AU - Phillip J. Schulte AU - Kent R. Bailey AU - Jae-Kwan Song AU - Jae K. Oh PY - 2026 JO - Mayo Clinic Proceedings DO - 10.1016/j.mayocp.2026.08.017 UR - https://doi.org/10.1016/j.mayocp.2026.08.017 ER -
APA
Padang, R., Hodara, R., Jan, M. F., Jain, R., Postalian, A., Zweig, B. M., Naqvi, T. Z., Levine, R. A., Dal-Bianco, J. P., Argulian, E., Pressman, G. S., Sengupta, P. P., Abbas, A. E., Cheng, W., Patel, A. K., Bhave, N. M., Chung, E. S., Sanchez, C. E., Barrett, T. C., Kort, S., Sohn, J., Pollak, P., Ali, M. T., Chadderdon, S., Zhao, Q., Gill, E., Sakr, F. E., Pereira, N. L., Vella, A., Schulte, P. J., Bailey, K. R., Song, J., & Oh, J. K. (2026). Efficacy and Safety of Evogliptin in Mild to Moderate Calcific Aortic Valve Stenosis: The EVOID-AS Trial Rationale and Study Design. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2026.08.017
Source records
- crossref · retrieved 2026-11-05T13:29:19.888Z